Полный текст:


Обзор литературы посвящен медико-социальным аспектам компенсации гипотиреоза. В нем обсуждаются современные принципы заместительной терапии, частота и причины декомпенсации, а также методы улучшения комплаентности пациентов. Также затрагиваются вопросы качества жизни и самочувствия пациентов на заместительной терапии препаратами тиреоидных гормонов.

Об авторах

T Morgunova

Кафедра эндокринологии

Yu Manuilova

Кафедра эндокринологии

V Fadeyev

Кафедра эндокринологии

Список литературы

1. Новик А.А., Ионова Т.И. Исследование качества жизни в медицине: Учеб. пособие; Под ред. Ю.Л. Шевченко. М.: ГЭОТАР-МЕД, 2004.

2. Петунина Н.А. Использование препаратов гормонов щитовидной железы в клинической практике// Клиническая тиреоидология. 2003. № 2.

3. Фадеев В.В. Современные концепции диагностики и лечения гипотиреоза у взрослых // Проблемы эндокринологии. 2004. Т. 50, № 2.

4. Anderson R.M., Fitzgerald J.T., Oh M.S. The relationship of diabetes-related attitudes and patients’ self-reported adherence // Diabetes Educ. 1993. V. 19. P. 287—292.

5. Arafah B. Increased need for thyroxine in women with hypothyroidism during estrogen therapy // The New England Journal of Medicine. 2000. V. 344(23). P. 1743—1749.

6. Bianchi G.P., Zaccheroni V., Solaroli E. et al. Health-related quality of life in patients with thyroid disorders // Qual Life Res. 2004. V. 13(1). P. 45—54.

7. Biondi B., Palmieri E.A., Lombardi G., Fazio S. Effects of subclinical thyroid dysfunction on the heart // Ann. Intern. Med. 2002. V. 137. P. 904—914.

8. Braverman L.E., Ingbar S.H., Sterling K. Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects // The Journal of clinical investigation. 1970. V. 49, N 5. P. 855—864.

9. Bunevidus R., Kaanavièius G., alinkevièius R., Prange A.J. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism // The New England Journal of Medicine. 1999. V. 340, N 6. P. 424—429.

10. Burmeister L.A., Ganguli M., Dodge H.H. et al. Hypothyroidism and cognition: preliminary evidence for a specific defect in memory // Thyroid. 2001. V. 11 P. 1177—1185.

11. Burnett J.R., Cooke R., Crooke M.J., Feek C.M. A study of L-thyroxine replacement // N. Z. Med. J. 1992. V. 105(930). P. 105—106.

12. Canaris G., Manowitz N., Mayor G., Ridgway E. Do traditional symptoms of hypothyroidism correlate with biochemical disease? // J. of Gen. Intern. Med. 1997. V. 12. P. 544—550.

13. Canaris G.J., Manowitz N.R., Mayor G., Ridgway E.C. The Colorado thyroid disease prevalence study // Arch. Internal Med. 2000. V. 160. P. 526—534.

14. Carr D., McLeod D.T., Parry G., Thornes H.M. Fine adjustment of thyroxine replacement dosage: comparison of the thyrotropin releasing hormone test using a sensitive thyrotropin assay with measurement of free thyroid hormones and clinical assessment // Clin Endocrinol. 1988. V. 28. P. 325—333.

15. Cassio A., Cacciari E., Cicognani A. et al. Treatment for congenital hypothyroidism: thyroxine alone or thyroxine plus triiodothyronine? // Pediatrics. 2003. V. 111, N. 5. P. 1055—1060.

16. Clyde P.W., Harari A. E., Getka E. J., Shakir K.M. Combined Levothyroxine Plus Liothyronine Compared With Levothyroxine Alone in Primary Hypothyroidism // JAMA. 2003. V. 290, N. 22. P. 2952—2958.

17. Cuthbertson D.J., Flynn R.W., Jung R.T., Leese G.P. Optimisation of thyroid hormone replacement using an automated thyroid register // Int. J. Clin. Pract. 2006. V. 60(6). P. 660—664.

18. Delamater A.M. Improving patient adherence // Clin. Diabetes. 2006. V. 24(2). P. 71—77.

19. Delamater A.M., Jacobson A.M., Anderson B.J. et al. Psychosocial therapies in diabetes: report of the Psychosocial Therapies Working Group // Diabetes Care. 2001. V. 24. P. 1286—1282.

20. Demers Laurence M., Spencer Carole A. NACB: Laboratory Support for the Diagnosis and Monitoring of Thyroid Disease. National Academy of Clinical Biochemistry, 2002.

21. Demet M., Ozmen B., Deveci A. et al. Depression and anxiety in hypothyroidism // West Indian Med. J. 2003. V. 52(3). P. 233—237

22. Diez J.J. Hypothyroidism in patients older than 55 years: an analysis of the etiology and assessment of the effectiveness of therapy // J.Gerontol a boil sci med sci. 2002. V. 57(5) / P. 315—320.

23. Evered D., Young E., Ormston B. et al. Treatment of hypothyroidism: a reappraisal of thyroxine therapy // BMJ. 1973. V. 3, N 5872. P. 131—134.

24. Flynn R.W., Morris A.D., Jung R.T. et al. Does an automated thyroid register improve the clinical management of hypothyroid patients? An observational study // Clin Endocrinol. 2005. V. 63. P. 116—118.

25. Frey H., Johannesen O., Kapelrud H., Sand T. Appropriate replacement dose of thyroxine in primary hypothyroidism // Acta Med. Scand. 1987. V. 222. P. 163—167.

26. Gold M.S., Pottash A.L., Extein I. Hypothyroidism and depression. Evidence from complete thyroid function evaluation // JAMA. 1981. V. 15, 245(19). P. 1919—1922.

27. Gordon M.B., Gordon M.C. Variations in adequate levothyroxine replacement therapy in patients with different causes of hypothyroidism // Endocrine Practice. 1999. V. 5(5). P. 233—238.

28. Gulseren S., Gulseren L., Hekimsoy Z. et al. Depression, anxiety, health-related quality of life, and disability in patients with overt and subclinical thyroid dysfunction // Arch. Med. Res. 2006. V. 37, N 1. P. 133—139.

29. Haggerty J.J.Jr., Prange A.J. Borderline hypothyroidism an depression // Ann. Rev. of Med. 1995. V. 46. P.37—46.

30. Hanna F., Lazarus H., Scanlon M. Controversial aspects of thyroid disease // Brit. Med. J. 1999.V. 319. P. 894—898.

31. Havrankova J., Lahaie R. Levothyroxine binding by sucralfate // Ann. of Intern. Med. 1992. V. 117. P. 445—446.

32. Helfand M., Crapo L. Monitoring therapy in patients taking levothyroxine // Ann. of Intern. Med. 1990. V. 113, N 6. P. 450—454.

33. Howland R.H. Thyroid dysfunction in refractory depression: implication for pathophysiology and treatment // J. Clin. Psychiatry. 1993. V. 54 (2). P.47—54.

34. Hueston W. Treatment of hypothyroidism // American family physician. 2001. V. 64. P. 1717—1724.

35. Joffe R.T., Levitt A.J. Major depression and subclinical (grade 2) hypothyroidism // Psychoneuroendocrinology. 1992. V. 17(2—3). P. 215—221.

36. Ladenson P. Psychological wellbeing in patients // Clin.l Endocrinol. 2002. V. 57. P. 575—576.

37. Lee Vivian W.Y., Leung Pak Yug. Glycemic control and medication compliance in diabetic patients in a pharmacist-managed clinic in Hong Kong // Am. J. Health—Syst. Pharm. 2003. V. 60, N 24. P. 2593—2596.

38. Leese G.P., Jung R.T., Scott A. et al. Long-term follow-up of treated hyperthyroid and hypothyroid patients // Health bull (Edinburg). 1993. V. 51(3). P. 177—183.

39. Levitt A., Silverberg J. T4 plus T3 treatment for hypothyroidism: a double-blind comparison with usual T4: 74th Annual Meeting of the American Thyroid Association, October 10-13. Los Angeles, California, 2002.

40. Liewendahl K., Helenius T., Lamberg B.A. et al. Free thyroxine, free triiodothyronine, and thyrotropin concentrations in hypothyroid and thyroid carcinoma patients receiving thyroxine therapy // Acta Endocrinol. 1987. V. 116(3). P. 418—424.

41. Lindsay R.S., Toft A.D. Hypothyroidism // Lancet. 1997. V. 349, N 9049. P. 413—417.

42. Mandell S.J., Brent G.A., Larsen P.R. Levothyroxine Therapy in Patients with Thyroid Disease // Ann. of Intern. Med. 1993. V. 119(6). P. 492—502.

43. McDermott M.T., Haugen B.R., Lezotte D.C. Management practices among primary care physicians and thyroid specialists in the care of hypothyroid patients // Thyroid. 2001. V. 11(8). P. 757—764.

44. McMillan C., Bradley C., Woodcock A., Razvi S., Weaver J. Design of new questionnaires to measure quality of life and treatment satisfaction in hypothyroidism // Thyroid. 2004. V. 14(11).P. 916—925.

45. Muir T., Zegarac M. Societal costs of exposure to toxic substances: economic and health costs of four case studies that are candidates for environmental causation // Environmental health perspectives. 2001. V. 109 (S. 6).

46. Munoz-Cruzado Poce M.J., Carcia Navas A.J., Moreno Gomez M.L. et al. Prevalence of thyroid disorders in patients diagnosed with depression // Attention primaria. 2000. V. 26(3). P. 176—179.

47. Oppenheimer J., Braverman L., Toft A. et al. A therapeutic controversy. Thyroid hormone treatment: when and what? // J. Clin. Endocrinol. Metab. 1995. V. 80, N 10. P. 2873—2876.

48. Osterweil D., Syndulko K., Cohen S.N. et al. Cognitive function in non-demented older adults with hypothyroidism // J. Am. Geriatr. Soc. 1992. V. 40. P. 325—335.

49. Parle J.V., Franklyn J.A., Cross K.W. et al. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentration in the elderly in the United Kingdom // Clin. Endocrinol. (Oxford). 1991. V. 34(1). P. 77—83.

50. Pies R.W. The diagnosis and treatment of subclinical hypothyroidism states in depression patients // Gen. Hosp. Psychiatry. 1997. V. 19(5). P. 344—354.

51. Pollock M.A., Sturrock A., Marshall K. et al. Thyroxine treatment in patients with symptoms of hypothyroidism but thyroid function tests within reference range: randomized double blind placebo controlled crossover trial // BMJ. 2001. V. 323. P. 891—895.

52. Rack S.K., Makela E.H. Hypothyroidism and depression: a therapeutic challenge // The annals of pharmacotherapy. 2000. V. 34, N 1. P. 1142—1145.

53. Razvi S., McMillant C., Weaver J. Instruments used in measuring symptoms, health status and quality of life in hypothyroidism: a systematic qualitative review // Clin. Endocrinol. 2005. V. 63. P. 617—624.

54. Romijn J.A., Smith J.W.A., Lamberts S.W.J. Intrinsic imperfections of endocrine replacement therapy// Eur. J. of Endocrinol. 2003. V. 149. P. 91—97.

55. Roti E., Minelli R., Gardini E., Braverman L.E. The use and misuse of thyroid hormone // Endocrine reviews. 1993. V. 14, N 4. P. 401—423.

56. Saravanan P., Chau F., Roberts N. et al. Psychological well-being in patients on ‘adequate’ doses of L-thyroxine // Clin. Endocrinol. 2002. V. 57, N 5. P. 577—585.

57. Saravanan P., Simmons D.J., Greenwood R. et al. Partial Substitution of Thyroxine (T4) with Tri-Iodothyronine in Patients on T4 Replacement Therapy: Results of a Large Community-Based Randomized Controlled Trial // J. Clin. Endocrinol. Metab. 2005. V. 90. P. 805—812.

58. Sawin C., Geller A., Hershman J., Castell W., Bacharach P. The aging thyroid. The use of thyroid hormone in older persons // JAMA. 1989. V. 12, 226(18). P. 2653—2655.

59. Sawka A. M., Gerstein H. C., Marriott M. J. et al. Does a Combination Regimen of Thyroxine (T4) and 3, 5, 3’- Triiodothyronine Improve Depressive Symptoms Better Than T4 Alone in Patients with Hypothyroidism? Results of a Double-Blind, Randomized, Controlled Trial // J. Clin. Endocrinol. and Metab. 2003. V. 88, N. 10. P. 4551—4555.

60. Sevinc A., Savli H. Hypothyroidism masquerading as depression: the role of noncompliance // J. Natl. Med. Assoc. 2004. 96 (3). P. 379—382.

61. Seshadri M., Samuel B., Kanagasabapathy A., Cherian A. Clinical scoring system for hypothyroidism: is it useful? // J. Gen. Intern. Med. 1989. V. 4(6). P. 490—492.

62. Singh N., Singh P., Hershman J. Effect of calcium carbonate on the absorption of levothyroxine // JAMA. 2000. V. 283(21). P. 2822—2825.

63. Schifferdecker E., Balz F., Jungmann E., Schoffling K. Compliance problems in therapy with levothyroxine // Med. Klin (Munich). 1990. V. 85(8). P. 477—480.

64. Stock J.M., Surks M.I., Oppenheimer J.H. Replacement dosage of L-thyroxine in hypothyroidism. A re-evaluation // N. Engl. J. Med. 1974. V. 290. P. 529—533.

65. Surks M.I., Schadlow A.R., Stock J.M., Oppenheimer J.H. Determination of iodothyronine absorption and conversion of L-thyroxine (T4 ) to L-triiodothyronine (T3 ) using turnover rate techniques // The Journal of clinical investigation. 1973. V. 52, N4. P. 805—811.

66. Toft A. Thyroxine therapy // The New England journal of medicine. 1994. V. 331(3). P. 174—180.

67. Toft A.D. Thyroid hormone replacement — one hormone or two? // N. Engl. J. Med. 1999. V. 340. P. 469—470.

68. Vanderpump M., Tunbridge W., French J. et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey // Clin. Endocrinol. 1995. V. 43(1). P. 55—68.

69. Wekking E., Appelhof B., Fliers E., Schene A. et al. Cognitive functioning and well-being in euthyroid patients on thyroxine replacement therapy for primary hypothyroidism // Eur. journal of Endocrinol. 2005. V. 153(6). P. 747—753.

70. Walsh J.P., Shiels L., Lim E.M. et al. Combined thyroxine/liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary hypothyroidism // J. Clin. Endocrinol. Metab. 2003. V. 88. P. 4543—4550.

71. Walsh J.P., Ward L.C., Burke V., Bhagat C.I. et al. Small changes in thyroxine dosage do not produce measurable changes in hypothyroid symptoms, well-being or quality of life: results of a double blind, randomized clinical trial // J. Clin. Endocrinol. Metab. 2006. V. 91. P. 2624—2630.

72. Watt T., Groenvold M., Rasmussen A.K., Bonnema S.J. et al. Quality of life in patients with benign thyroid disorders. A review // Eur. J. Endocrinol. 2006. V. 154, N.4. P. 501—510.

73. Weetman A.P. // Hypothyroidism: screening and subclinical disease // Brit. Med. J. 1997. V. 314. P. 1175—1178.

74. Wiersinga W.M. Adult hypothyroidism in Thyroid Disease Manager, 2004.

75. Zulewski H., Muller B., Exer P. et al. Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls // J. of Clin. Endocrinol. and Metab. 1997. V. 82, N 3. P. 771—776.

Для цитирования:

Morgunova T., Manuilova Y., Fadeyev V. МЕДИКО-СОЦИАЛЬНЫЕ АСПЕКТЫ ЗАМЕСТИТЕЛЬНОЙ ТЕРАПИИ ГИПОТИРЕОЗА: ФАКТОРЫ, ВЛИЯЮЩИЕ НА КАЧЕСТВО КОМПЕНСАЦИИ. Клиническая и экспериментальная тиреоидология. 2007;3(3):12-24.

For citation:

., ., . Social and Medical Aspects of Replacement Thyroxine Therapy: Factors of Compensation Quality. Clinical and experimental thyroidology. 2007;3(3):12-24. (In Russ.)

Просмотров: 11

Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.

ISSN 1995-5472 (Print)
ISSN 2310-3787 (Online)